Clinical Trial Update: Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis With or Without the Presence of Nasal Polyps [Phase 3]

View source ↗

Summary

Phase 3 trial results for intranasal OPN-375 in chronic rhinosinusitis with or without nasal polyps have been posted following study completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis
• Rhinosinusitis Without Nasal Polyps
• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• OPN-375

Snippet

Sponsor: Optinose US Inc. | Conditions: Chronic Rhinosinusitis | Phase 3 | Status: COMPLETED | Results posted: 2023-09-18